SELE and breast carcinoma: In particular, the observation that increased Fra-2 expression can lead to increased attachment of the cancer cells to E-selectin suggests that Fra-2 also modulates selectin-binding sites in breast cancer cells in vivo and thus allows the tumour cells to adhere to the vascular endothelium via E-selectin.